Olympus Capital Investments makes opportunistic investments in a myriad of industries and specializations, and in varying stages of development. OCI’s investments range from completely passive to active, including holding board seats. Regardless of its role, OCI strives to provide value to its portfolio companies beyond just capital, including through cross collaborations and introductions across the portfolio. Examples of current investments include:

  • Seed capital in a company producing and touring high-quality traveling exhibitions of art, science, history, and popular culture to a diverse audience worldwide
  • Preferred equity investment in a publicly-traded leading streaming content aggregation and distribution company
  • Private investment in a public equity (PIPE) late-stage biotech company addressing diseases of the central nervous system with a focus on major depressive disorder
  • PIPE in a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases including cystic fibrosis and chronic pancreatitis
  • Late-stage investment in a company focusing on the secure access, storage, management, and protection of digital data and information through its product suite
  • Various investments in a series limited liability company providing unique opportunities for early investment in late-round venture capital, secondary interests, and pre-IPO investments
  • Early-stage investment in a company developing the leading cloud-based platform for the solar and energy storage industry
  • Limited partner investment in a niche private equity fund investing exclusively across the cannabis space, including in product, retail, technology, distribution, and other industry-related channels